Hospital antibiotic use and resistance: A relationship that is difficult to measure and complex to interpret;Consumo de antimicrobianos y resistencia en el hospital: Una relación difícil de medir y compleja de interpretar

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 27, Issue 8, 2009, Pages 437-440

  Cantón, Rafael ^a   Cobo, Javier ^a  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; CEPHALOSPORIN DERIVATIVE; CLOXACILLIN; COTRIMOXAZOLE; ERYTHROMYCIN; LINCOSAMIDE; MACROLIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; BACTEROIDES FRAGILIS; DRUG USE; EDITORIAL; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; HOSPITAL CARE; HOSPITAL INFECTION; HUMAN; KLEBSIELLA; NONHUMAN; PROTEUS MIRABILIS; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS;

EID: 70349446570     PISSN: 0213005X     EISSN: 15781852     Source Type: Journal    
DOI: 10.1016/j.eimc.2009.04.004     Document Type: Article

References (33)

1. S.B. Levy Antibiotic resistance: An ecological imbalance Ciba Found Symp 207 1997 1 9
2. R. Cantón, T.M. Coque, and F. Baquero Multi-resistant Gram-negative bacilli: From epidemics to endemics Curr Opin Infect Dis 16 2003 315 325
3. F. Baquero From pieces to patterns: Evolutionary engineering in bacterial pathogens Nat Rev Microbiol 2 2004 510 518
4. N. Van de Sande-Bruinsma, H. Grundmann, D. Verloo, E. Tiemersma, J. Monen, H. Goossens et al. European Surveillance of Antimicrobial Consumption Project Group Antimicrobial drug use and resistance in Europe Emerg Infect Dis 14 2008 1722 1730
5. S. Coenen, M. Ferech, F.M. Haaijer-Ruskamp, C.C. Butler, R.H. Vander Stichele, and T.J. Verheij et al. European Surveillance of Antimicrobial Consumption (ESAC): Quality indicators for outpatient antibiotic use in Europe Qual Saf Health Care 16 2007 440 445
6. R.H. Vander Stichele, M.M. Elseviers, M. Ferech, S. Blot, H. Goossens European Surveillance of Antibiotic Consumption (ESAC) Project Group Hospital consumption of antibiotics in 15 European countries: Results of the ESAC Retrospective Data Collection (1997-2002) J Antimicrob Chemother 58 2006 159 167
7. Maortua H, Canut A, Ibáñez B, Martínez D, Domingo MJ, Labora A. Relación entre la resistencia bacteriana intrahospitalaria y el consumo de antimicrobianos durante un período de trece años. Enferm Infec Microbiol Clin. 2009. doi:10.1016/j.eimc.2008.09.017.
8. R. Ben-Ami, M.J. Schwaber, S. Navon-Venezia, D. Schwartz, M. Giladi, and I. Chmelnitsky et al. Influx of extended-spectrum beta-lactamase-producing enterobacteriaceae into the hospital Clin Infect Dis 42 2006 925 934
9. W.R. Jarvis Infection control and changing healthcare delivery systems Emerg Infect Dis 7 2001 170 173
10. E. Cercenado, and E. Ruiz de Gopegui Staphylococcus aureus resistente a la meticilina de origen comunitario Enferm Infecc Microbiol Clin 26 2008 19 24
11. J. Rodríguez-Baño, and M.D. Navarro Extended-spectrum beta-lactamases in ambulatory care: A clinical perspective Clin Microbiol Infect 14 2008 104 110
12. F.M. MacKenzie, J.M. López-Lozano, D.L. Monnet, D. Stuart, A. Beyaert, and R. Wilson et al. Temporal relationship between prevalence of meticillin-resistant Staphylococcus aureus (MRSA) in one hospital and prevalence of MRSA in the surrounding community: A time-series analysis J Hosp Infect 67 2007 225 231
13. M.A. Aldeyab, D.L. Monnet, J.M. López-Lozano, C.M. Hughes, M.G. Scott, and M.P. Kearney et al. Modelling the impact of antibiotic use and infection control practices on the incidence of hospital-acquired methicillin-resistant Staphylococcus aureus: A time-series analysis J Antimicrob Chemother 62 2008 593 600
14. A.M. Rogues, C. Dumartin, B. Amadéo, A.G. Venier, N. Marty, and P. Parneix et al. Relationship between rates of antimicrobial consumption and the incidence of antimicrobial resistance in Staphylococcus aureus and Pseudomonas aeruginosa isolates from 47 French hospitals Infect Control Hosp Epidemiol 28 2007 1389 1395
15. C. MacDougall, S.E. Harpe, J.P. Powell, C.K. Johnson, M.B. Edmond, and R.E. Polk Pseudomonas aeruginosa, Staphylococcus aureus, and fluoroquinolone use Emerg Infect Dis 11 2005 1197 1204
16. M.J. Bonten, S. Slaughter, A.W. Ambergen, M.K. Hayden, J. Van Voorhis, and C. Nathan et al. The role of "colonization pressure" in the spread of vancomycin-resistant enterococci: An important infection control variable Arch Intern Med 158 1998 1127 1132
17. N. Jumbe, A. Louie, R. Leary, W. Liu, M.R. Deziel, and V.H. Tam et al. Application of a mathematical model to prevent in vivo amplification of antibiotic-resistant bacterial populations during therapy J Clin Invest 112 2003 275 285
18. J.F. Mohr, A. Jones, L. Ostrosky-Zeichner, A. Wanger, and G. Tillotson Associations between antibiotic use and changes in susceptibility patterns of Pseudomonas aeruginosa in a private, university-affiliated teaching hospital: An 8-year-experience: 1995-2002 Int J Antimicrob Agents 24 2004 346 351
19. D.N. Gilbert, S.J. Kohlhepp, K.A. Slama, G. Grunkemeier, G. Lewis, and R.J. Dworkin et al. Phenotypic resistance of Staphylococcus aureus, selected Enterobacteriaceae, and Pseudomonas aeruginosa after single and multiple in vitro exposures to ciprofloxacin, levofloxacin, and trovafloxacin Antimicrob Agents Chemother 45 2001 883 892
20. M. Christ-Crain, D. Stolz, R. Bingisser, C. Müller, D. Miedinger, and P.R. Huber et al. Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: A randomized trial Am J Respir Crit Care Med 174 2006 84 93
21. F. Baquero Low-level antibacterial resistance: A gateway to clinical resistance Drug Resist Updat 4 2001 93 105
22. M.J. De Regt, L.E. Van der Wagen, J. Top, H.E. Blok, T.E. Hopmans, and A.W. Dekker et al. High acquisition and environmental contamination rates of CC17 ampicillin-resistant Enterococcus faecium in a Dutch hospital J Antimicrob Chemother 62 2008 1401 1406
23. A.D. Harris, J.C. McGregor, J.A. Johnson, S.M. Strauss, A.C. Moore, and H.C. Standiford et al. Risk factors for colonization with extended-spectrum beta-lactamase-producing bacteria and intensive care unit admission Emerg Infect Dis 13 2007 1144 1149
24. A.M. Hammerum, O.E. Heuer, H.D. Emborg, L. Bagger-Skjøt, V.F. Jensen, and A.M. Rogues et al. Danish integrated antimicrobial resistance monitoring and research program Emerg Infect Dis 13 2007 1632 1639
25. T.M. Coque, F. Baquero, and R. Cantón Increasing prevalence of ESBL-producing Enterobacteriaceae in Europe Euro Surveill 13 2008 19044
26. M.I. Morosini, M. García-Castillo, T.M. Coque, A. Valverde, A. Novais, and E. Loza et al. Antibiotic coresistance in extended-spectrum-beta- lactamase-producing Enterobacteriaceae and in vitro activity of tigecycline Antimicrob Agents Chemother 50 2006 2695 2699
27. J.J. Rahal, C. Urban, and S. Segal-Maurer Nosocomial antibiotic resistance in multiple gram-negative species: Experience at one hospital with squeezing the resistance balloon at multiple sites Clin Infect Dis 34 2002 499 503
28. A. Sandiumenge, and J. Rello ¿Rotación cíclica de antibióticos: es oro todo lo que reluce? Enferm Infecc Microbiol Clin 21 2003 93 100
29. J. Garau Impact of antibiotic restrictions: The ethical perspective Clin Microbiol Infect 12 2006 16 24
30. rd ICAAC abstracts. Washington: American Society for Microbiology; 2003. p 391.
31. V.I. Enne, D.M. Livermore, P. Stephens, and L.M. Hall Persistence of sulphonamide resistance in Escherichia coli in the UK despite national prescribing restriction Lancet 357 2001 1325 1328
32. D.M. Livermore Minimising antibiotic resistance Lancet Infect Dis 5 2005 450 459
33. J.P. Burke Antibiotic resistance-squeezing the balloon? JAMA 280 1998 1270 1271